Roche, Sangamo Ink Licensing Deal for Neuro Drugs

Seeking AlphaAug 6 09:03 ET

Roche Holding Non-GAAP EPS of CHF 10.23, Revenue of CHF 29.85B; Raises FY24 Outlook

Seeking AlphaJul 25 03:16 ET

Reported Thursday, Roche's Genentech Halts SKYSCRAPER-06 Trial After Tiragolumab Plus Tecentriq And Chemotherapy Show Reduced Efficacy Compared To Comparator Arm

BenzingaJul 5 02:54 ET

Roche's Genentech Receives FDA Approval For Vabysmo Prefilled Syringe (PFS) To Treat Three Leading Causes Of Vision Loss

BenzingaJul 5 01:57 ET

Roche's VENTANA DP 200 Digital System Approved For Diagnostic Use By FDA

BenzingaJun 18 02:03 ET

Reported Saturday, Genentech's Phase III STARGLO Study Shows Columvi Increases Survival For Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma

BenzingaJun 17 03:47 ET